Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001738266-18-000002
Filing Date
2018-06-05
Accepted
2018-06-05 14:58:57
Documents
1
Effectiveness Date
2018-06-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6422
  Complete submission text file 0001738266-18-000002.txt   7450
Mailing Address 6894 LAKEMONT CIRCLE WEST BLOOMFIELD MI 48323
Business Address 6894 LAKEMONT CIRCLE WEST BLOOMFIELD MI 48323 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001738266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-313905 | Film No.: 18880865